Cefuroxime Axetil
Product Images NDC 67296-2088

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefuroxime Axetil (NDC 67296-2088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (125 mg (20 Tablets Bottle))

Label for Cefuroxime Axetil Tablets, USP 125 mg by Aurobindo Pharma USA, Inc. The label includes the NDC 65862-698-20 and states the package contains 20 film-coated tablets. Storage instructions specify 20° to 25°C with permitted excursions and a caution to keep out of reach of children. The product is made in India and distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (250 mg (20 Tablets Bottle))

Label for Cefuroxime Axetil Tablets, USP 250 mg, distributed by Aurobindo Pharma USA, Inc. The label states each film-coated tablet contains Cefuroxime Axetil equivalent to 250 mg of cefuroxime. It includes storage instructions, a warning to keep out of the reach of children, and indicates the product is made in India. The package contains 20 tablets.*

FDA Label Image

Package Label-principal Display Panel -500 mg (20 Tablets Bottle) (Cefuroxime Axetil Fig3)

Label for Cefuroxime Axetil Tablets USP 500 mg, 20 tablets, by Aurobindo Pharma USA, Inc. The label indicates the product is prescription only and provides storage instructions, distributor address, and manufacturing origin (India). The label includes dosing directions to see the package insert and a warning to keep out of reach of children.*

FDA Label Image

Chemical Structure (Cefuroxime Axetil Str)

Chemical structure of Cefuroxime Axetil, the active ingredient in the product labeled by Redpharm Drug with NDC 67296-2088. The structure shows multiple rings including a thiazole, and functional groups such as amide, ester, and ether moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.